Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02709928 · ClinicalTrials.gov registry record · Phase 1
Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects
A Phase 1 study of Healthy Adults, Elderly Subjects, sponsored by Theravance Biopharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT02709928: Completed Phase 1 study of Healthy Adults, Elderly Subjects, sponsored by Theravance Biopharma.
NCT02709928 is a Phase 1 study of Healthy Adults, Elderly Subjects that has completed, run by Theravance Biopharma. The registered enrollment target is 50 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02709928, a Phase 1 study of Healthy Adults, Elderly Subjects, has completed, sponsored by Theravance Biopharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TD-0714 in healthy adult and elderly subjects
Conditions Studied
Interventions
- DRUG Placebo
- DRUG TD-0714
Study Locations (1)
Nebraska
- Celerion - Lincoln
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-03 |
| Est. Completion | 2016-12 |
| Phase | Phase 1 |
What the finished NCT02709928 record still lists
NCT02709928 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (17% lower).
The record links to 1 condition, with Healthy Adults, Elderly Subjects appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02709928 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT02709928 about?
NCT02709928 is a clinical study titled "Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects". Multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TD-0714 in healthy adult and elderly subjects
What is the current status of trial NCT02709928?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2016-03. Estimated completion is 2016-12.
What conditions does trial NCT02709928 study?
This clinical trial studies the following conditions: Healthy Adults, Elderly Subjects.
What interventions are being tested in trial NCT02709928?
The interventions under investigation include: Placebo (DRUG), TD-0714 (DRUG).
Who is sponsoring clinical trial NCT02709928?
This trial is sponsored by Theravance Biopharma, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02709928 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adults, Elderly Subjects
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02709928's enrollment target sits among peer trials
50 973rd of 2000 higher than 984 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia